R01 DA009803/DA/NIDA NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
2007	4
2008	3
2009	2
2010	3
2011	1
2012	2
2022	0

1

Human immunodeficiency virus testing practices among buprenorphine-prescribing physicians.

Edelman EJ, Dinh AT, Moore BA, Schottenfeld RS, Fiellin DA, Sullivan LE. Edelman EJ, et al. J Addict Med. 2012 Jun;6(2):159-65. doi: 10.1097/ADM.0b013e31824339fc. J Addict Med. 2012. PMID: 22367499 Free PMC article.

2

Opioids, chronic pain, and addiction in primary care.

Barry DT, Irwin KS, Jones ES, Becker WC, Tetrault JM, Sullivan LE, Hansen H, O'Connor PG, Schottenfeld RS, Fiellin DA. Barry DT, et al. J Pain. 2010 Dec;11(12):1442-50. doi: 10.1016/j.jpain.2010.04.002. Epub 2010 Jun 2. J Pain. 2010. PMID: 20627817 Free PMC article.

3

Patient satisfaction with primary care office-based buprenorphine/naloxone treatment.

Barry DT, Moore BA, Pantalon MV, Chawarski MC, Sullivan LE, O'Connor PG, Schottenfeld RS, Fiellin DA. Barry DT, et al. J Gen Intern Med. 2007 Feb;22(2):242-5. doi: 10.1007/s11606-006-0050-y. J Gen Intern Med. 2007. PMID: 17356993 Free PMC article. Clinical Trial.

4

Cost-effectiveness of long-term outpatient buprenorphine-naloxone treatment for opioid dependence in primary care.

Schackman BR, Leff JA, Polsky D, Moore BA, Fiellin DA. Schackman BR, et al. J Gen Intern Med. 2012 Jun;27(6):669-76. doi: 10.1007/s11606-011-1962-8. Epub 2012 Jan 4. J Gen Intern Med. 2012. PMID: 22215271 Free PMC article.

5

Integrating buprenorphine treatment into office-based practice: a qualitative study.

Barry DT, Irwin KS, Jones ES, Becker WC, Tetrault JM, Sullivan LE, Hansen H, O'Connor PG, Schottenfeld RS, Fiellin DA. Barry DT, et al. J Gen Intern Med. 2009 Feb;24(2):218-25. doi: 10.1007/s11606-008-0881-9. Epub 2008 Dec 17. J Gen Intern Med. 2009. PMID: 19089500 Free PMC article.

6

Effect of incarceration history on outcomes of primary care office-based buprenorphine/naloxone.

Wang EA, Moore BA, Sullivan LE, Fiellin DA. Wang EA, et al. J Gen Intern Med. 2010 Jul;25(7):670-4. doi: 10.1007/s11606-010-1306-0. Epub 2010 Mar 6. J Gen Intern Med. 2010. PMID: 20213205 Free PMC article. Clinical Trial.

7

Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients.

Moore BA, Fiellin DA, Barry DT, Sullivan LE, Chawarski MC, O'Connor PG, Schottenfeld RS. Moore BA, et al. J Gen Intern Med. 2007 Apr;22(4):527-30. doi: 10.1007/s11606-007-0129-0. J Gen Intern Med. 2007. PMID: 17372805 Free PMC article.

8

Utility of sweat patch testing for drug use monitoring in outpatient treatment for opiate dependence.

Chawarski MC, Fiellin DA, O'Connor PG, Bernard M, Schottenfeld RS. Chawarski MC, et al. J Subst Abuse Treat. 2007 Dec;33(4):411-5. doi: 10.1016/j.jsat.2007.03.004. Epub 2007 May 23. J Subst Abuse Treat. 2007. PMID: 17512157 Free PMC article. Clinical Trial.

9

Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors.

Sullivan LE, Moore BA, Chawarski MC, Pantalon MV, Barry D, O'Connor PG, Schottenfeld RS, Fiellin DA. Sullivan LE, et al. J Subst Abuse Treat. 2008 Jul;35(1):87-92. doi: 10.1016/j.jsat.2007.08.004. Epub 2007 Oct 15. J Subst Abuse Treat. 2008. PMID: 17933486 Free PMC article. Clinical Trial.

10

The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependence.

Sullivan LE, Moore BA, O'Connor PG, Barry DT, Chawarski MC, Schottenfeld RS, Fiellin DA. Sullivan LE, et al. Am J Addict. 2010 Jan-Feb;19(1):53-8. doi: 10.1111/j.1521-0391.2009.00003.x. Am J Addict. 2010. PMID: 20132122 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results